NCT04771143View on ClinicalTrials.gov

Study to Assess Safety, Tolerability, and Interactions of Cocaine and Oral AFQ056

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

July 21, 2021

Primary Completion Date

January 3, 2022

Study Completion Date

January 3, 2022

Conditions
Cocaine Use Disorder
Interventions
DRUG

AFQ056

oral administration

DRUG

Placebo

matching placebo for oral administration

Sponsors
All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Novartis Pharmaceuticals

INDUSTRY